Comparison of tuberculin skin test response after three modalities of neonatal BCG vaccination

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 5, 2007, Pages 493-496

  Castro Rodriguez, Jose A ^a   Mallol, Javier ^a   Andrade, Rosa ^a   Muñoz, Mónica ^b   Azzini, Ivanna ^c  

^a Hospital El Pino   (Chile)

^b Ministerio de Salud de Chile   (Chile)

^c Chilean Public Health Institute   (Chile)

Author keywords

BCG vaccine; Chile; Immunization; Tuberculin test; Tuberculosis; Vaccination

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ARTICLE; CHILE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MALE; MORBIDITY; NEWBORN; NORMAL HUMAN; OSTEITIS; PREVALENCE; RESPIRATORY TRACT INFECTION; SCAR; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

BCG VACCINE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; MYCOBACTERIUM BOVIS; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

EID: 33947099499     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2006.08.003     Document Type: Article

References (24)

1. Behr M.A. BCG-different strains, different vaccines?. Lancet Infect. Dis. 2 (2002) 86-92
2. Bouros D., Zeros G., Panaretos C., Vassilatos C., and Siafakas N. Palpation vs. pen method for the measurement of skin tuberculin reactions (Mantoux test). Chest 99 (1991) 416-419
3. Bunch-Christensen K. Evaluation of BCG in children, the effect of strain and dose. J. Biol. Stand. 5 (1977) 159-164
4. Colditz G.A., Berkey C.S., Mosteller F., Brewer T.F., Wilson M.E., Burdick E., and Fineberg H.V. The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96 (1995) 29-35
5. D'Arcy H., Sutherland I., and Thomas J. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines. Tubercle 48 (1967) 201-210
6. Davids V., Hanekom W.A., Mansoor N., Gamieldien H., Gelderbloem S.J., Hawkridge A., Hussey G.D., Hugher E.J., Soler J., Murray R.A., Ress S.R., and Kapplan G. The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. J. Infect. Dis. 193 (2006) 531-536
7. Donald P. Childhood tuberculosis. Curr. Opin. Pulm. Med. 6 (2000) 187-192
8. Espinal M.A., Laszlo A., Simonsen L., Boulahbal F., Kim S.J., Reniero A., Hoffner S., Rieder H.L., Binkin N., Dye C., Williams R., and Raviglione M.C. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-tuberculosis Drug Resistance Surveillance. N. Engl. J. Med. 344 (2001) 1294-1303
9. Gheorghiu M. The present and future role of BCG vaccine in tuberculosis control. Biologicals 18 (1990) 135-141
10. Ginsberg A.M. What's new in tuberculosis vaccines? Bull. World Health Organ. 80 (2002) 483-488
11. Guerin N., Teulieres L., Noba A., Schlumberger M., Bregere P., and Chauvin P. Comparison of the safety and immunogenicity of the lyophilized Merieux seed and the World Health Organization working reference BCG vaccines in school-aged children in Senegal. Vaccine 17 (1999) 105-109
12. Hart P.D.A., and Sutherland I. BCG and vole bacillus in the prevention of tuberculosis in adolescent and early adult life: final report to the Medical Research Council. Br. Med. J. 2 (1977) 293-295
13. Ildirim I., Hacimustafaoglu M., and Ediz B. Correlation of tuberculin induration with the number of Bacillus Calmette-Guerin vaccines. Pediatr. Infect. Dis. 14 (1995) 1060-1063
14. Kampmann B., Tena G.N., Mzazi S., Eley B., Young D.B., and Levin M. Novel human in vitro system for evaluating antimycobacterial vaccines. Infect. Immun. 72 (2004) 6401-6407
15. Lao L., and De Guia T. Tuberculin skin testing: determinants and reaction. Respirology 4 (1999) 311-317
16. Mallol J., Girardi G., Quezada A., Montenegro C., and Espinoza P. Tuberculin reaction in healthy infants vaccinated with BCG at birth. Rev. Chil. Pediatr. 61 (1990) 252-257
17. Menzies R., and Vissandjee B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am. Rev. Respir. Dis. 145 (1992) 621-625
18. Snider D.E. Bacille Calmette-Guerin vaccinations and tuberculin skin tests. JAMA 253 (1985) 3438-3439
19. Suciliene E., Ronne T., Plesner A.M., Semenaite B., Slapkauskaite D., Larsen S.O., and Haslov K. Infant BCG vaccination study in Lithuania. Int. J. Tuberc. Lung Dis. 3 (1999) 956-961
20. Valenzuela M.T., Ferrer X., Leal I., Pacheco M., Castillo N., and Cumsille F. Comparative study of the efficacy of two types of BCG vaccines administered in different doses. Rev. Med. Chil. 126 (1998) 1126-1131
21. Vijayalakshmi V., Murthy K.J., Kumar S., and Kiran A.L. Comparison of the immune responses in children vaccinated with three strains of BCG vaccine. Indian Pediatr. 32 (1995) 979-982
22. WHO. Special Program on AIDS and Expanded Program on Immunization. Joint statement. Consultation on human immunodeficiency (HIV) and routine childhood immunization. Wkly Epidemiol. Rec. 62 (1987) 297-299
23. Young T., and Mirdad S. Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination. Tuber. Lung Dis. 73 (1992) 94-100
24. Zuñiga M. Situación de la tuberculosis en Chile-2002 y su posible evolución. Rev. Chil. Enf. Respir. 19 (2003) 179-191